Leo Pharma CEO: "The strategy has started to crystalize and yield a return"
![Leo Pharma's attention now turns to securing speedy growth, CEO Christophe Bourdon says | Photo: Leo Pharma/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14386963.ece/ALTERNATES/schema-16_9/doc7mnniv5g73twl6tx5tl.jpg)
Leo Pharma’s strategy is beginning to pay off, Chief Executive Officer Christophe Bourdon tells Danish business daily Børsen, also revealing some key figures for the company’s performance in the first half of 2022. Bourdon’s focus is now accelerating growth.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Leo Pharma's energy contingency plan approved
For subscribers
Leo Pharma appoints new board member
For subscribers